1. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008; 17:304–309.
Article
2. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med. 2003; 115:26–32.
Article
3. Daudon M, Jungers P, Bazin D. Peculiar morphology of stones in primary hyperoxaluria. N Engl J Med. 2008; 359:100–102.
Article
4. Jacob DE, Grohe B, Geßner M, Beck BB, Hoppe B. Kidney stones in primary hyperoxaluria: new lessons learnt. PLoS One. 2013; 8:e70617.
Article
5. Dussol B, Geider S, Lilova A, Léonetti F, Dupuy P, Daudon M, et al. Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone protein matrix. Urol Res. 1995; 23:45–51.
6. Abdel-Halim RE, Abdel-Halim MR. A review of urinary stone analysis techniques. Saudi Med J. 2006; 27:1462–1467.
7. Sutor DJ, Scheidt S. Identification standards for human urinary calculus components, using crystallographic methods. Br J Urol. 1968; 40:22–28.
Article
8. Schubert G. Stone analysis. Urol Res. 2006; 34:146–150.
Article
9. Hesse A, Kruse R, Geilenkeuser WJ, Schmidt M. Quality control in urinary stone analysis: results of 44 ring trials (1980-2001). Clin Chem Lab Med. 2005; 43:298–303.
Article
10. Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol. 2016; 69:468–474.
Article
11. Primiano A, Persichilli S, Gambaro G, Ferraro PM, D'Addessi A, Cocci A, et al. FT-IR analysis of urinary stones: a helpful tool for clinician comparison with the chemical spot test. Dis Markers. 2014; 2014:176165.
Article
12. Selvaraju R, Thiruppathi G, Raja A. FT-IR spectral studies on certain human urinary stones in the patients of rural area. Spectrochim Acta A Mol Biomol Spectrosc. 2012; 93:260–265.
Article
13. Sun X, Shen L, Cong X, Zhu H, Lv J, He L. Infrared spectroscopic analysis of urinary stones (including stones induced by melamine-contaminated milk powder) in 189 Chinese children. J Pediatr Surg. 2011; 46:723–728.
Article
14. Scholz D, Schwille PO, Ulbrich D, Bausch WM, Sigel A. Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine. Urol Res. 1979; 7:161–170.
Article
15. Dall'era JE, Kim F, Chandhoke PS. Gender differences among Hispanics and Caucasians in symptomatic presentation of kidney and ureteral stones. J Endourol. 2005; 19:283–286.
16. Daudon M, Bounxouei B, Santa Cruz F, Leite da, Diouf B, Angwafoo FF 3rd, et al. Composition of renal stones currently observed in non-industrialized countries. Prog Urol. 2004; 14:1151–1161.
17. Pandeya A, Prajapati R, Panta P, Regmi A. Assessment of kidney stone and prevalence of its chemical compositions. Nepal Med Coll J. 2010; 12:190–192.
18. Hussain M. Enormity of urolithiasis in Sindh province. J Pak Med Assoc. 2014; 64:1337–1338.
19. Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Hussain M, Zafar MN, et al. The management of stone disease. BJU Int. 2002; 89:Suppl 1. 62–68.
Article